1. Home
  2. OFIX vs RCEL Comparison

OFIX vs RCEL Comparison

Compare OFIX & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

BUY

Current Price

$8.89

Market Cap

387.0M

Sector

Health Care

ML Signal

BUY

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

N/A

Current Price

$13.16

Market Cap

360.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFIX
RCEL
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.0M
360.9M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
OFIX
RCEL
Price
$8.89
$13.16
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
★ $13.00
$12.07
AVG Volume (30 Days)
★ 381.3K
281.2K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.39
27.20
EPS
N/A
★ N/A
Revenue
★ $822,312,000.00
$71,610,000.00
Revenue This Year
$3.48
$21.81
Revenue Next Year
$2.46
$25.84
P/E Ratio
N/A
★ N/A
Revenue Growth
2.85
★ 11.45
52 Week Low
$8.50
$3.22
52 Week High
$16.99
$13.50

Technical Indicators

Market Signals
Indicator
OFIX
RCEL
Relative Strength Index (RSI) 41.60 71.16
Support Level $8.68 $3.74
Resistance Level $9.92 N/A
Average True Range (ATR) 0.42 0.70
MACD 0.03 0.08
Stochastic Oscillator 30.03 87.35

Price Performance

Historical Comparison
OFIX
RCEL

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: